# Quanterix Completes Acquisition of Akoya Biosciences for Spatial Biology Expansion

> ma · REPORTED · 2025-07-08

Quanterix completed its acquisition of Akoya Biosciences on July 8, 2025, combining Quanterix's ultrasensitive biomarker detection capabilities with Akoya's spatial phenotyping platforms. The deal, valued at approximately $243 million, expands Quanterix's offering to biopharma and academic researchers seeking single-cell resolution tissue analysis.

About Quanterix: Quanterix is a life science tools company that develops ultrasensitive digital biomarker detection technology (Simoa) used in neurology, oncology, and inflammation research for biopharma and academic labs worldwide.

- Company: Quanterix
- Sector: life-science tools
- Primary source: https://www.sec.gov/Archives/edgar/data/1503274/000150327425000091/qtrx-20250630.htm

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.